John Lambris
www.lambris.com
0000-0002-9370-5776
6 papers found
Refreshing results…
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
Interlaboratory Comparison of Hydrogen–Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb
New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile
Missing publications? Search for publications with a matching author name.